Adalimumab-800CW
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adalimumab-800CW, covering 2025-08-19 to 2025-08-19. Get the full timeline:
Most recent: Clinical Trial Update: Fluorescence Imaging of IBD and RA Using Adalimumab-800CW [Phase 2]